We continue to streamline our medical specialty drug reviews by transitioning another drug review process from AIM to Anthem’s medical specialty drug review team.

What is changing?

  • Beginning on June 15, 2019, for all requests, regardless of service date, providers will need to submit a new prior authorization request by contacting Anthem’s medical specialty drug review team:
    • o by phone at 833-293-0659 or
    • o by fax at 888-223-0550 or
    • o Online access at com available 24/7.
  • All inquiries about an existing request (initially submitted to AIM or Anthem), peer-to-peer review, or reconsideration will be managed by Anthem’s medical specialty drug review team.

 

What is not changing?

  • AIM will continue to be responsible for performing medical oncology drug reviews for existing commercial medical benefit for our employer group business.
  • Medical policies and clinical guidelines for non-drug specialty topics will continue to reside at the Office of Medical Policy & Technology Assessment (OMPTA) homepage
  • Post Service Clinical Coverage Reviews and Grievance and Appeals process and teams will not change.

 

For your convenience here is a summary of the medical specialty drug changes:

 

Action

Contact

 

 

Prior to June 15, 2019

 

Submit a new prior authorization request

 

Inquire about an existing request

Call AIM at
866-714-1107,

8:00 a.m. – 5:00p.m.

or

Access online at availity.com available 24/7

 

 

 

 

Beginning June 15, 2019

 

Submit a new prior authorization request for medical specialty drug reviews

Call Anthem at
833-293-0659 or fax us at 888-223-0550 

or

Access online at availity.com available 24/7  

 

Inquire about an existing request (initially submitted to AIM or Anthem), peer-to-peer review, or reconsideration

 

Call Anthem at 1-833-293-0659

 



Featured In:
Anthem June 2019 Provider News - Georgia